Amicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat EstimatesZacks Investment Research • 11/06/24
Wall Street Analysts Predict a 51.09% Upside in Amicus Therapeutics (FOLD): Here's What You Should KnowZacks Investment Research • 11/04/24
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024GlobeNewsWire • 11/01/24
Amicus Therapeutics (FOLD) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 10/30/24
Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024GlobeNewsWire • 10/28/24
5 Biotech Stocks Likely to Outperform as Industry Prospects Look BrightZacks Investment Research • 10/24/24
American Citizens Abroad (ACA) joins amicus brief supporting voting by U.S. citizens overseasGlobeNewsWire • 10/21/24
Why Amicus Therapeutics (FOLD) is a Top Momentum Stock for the Long-TermZacks Investment Research • 10/21/24
Can Amicus Therapeutics (FOLD) Run Higher on Rising Earnings Estimates?Zacks Investment Research • 10/18/24
Amicus Therapeutics (FOLD) Just Flashed Golden Cross Signal: Do You Buy?Zacks Investment Research • 10/18/24
How Much Upside is Left in Amicus Therapeutics (FOLD)? Wall Street Analysts Think 43.44%Zacks Investment Research • 10/18/24
Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?Zacks Investment Research • 10/18/24
Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder DrugBenzinga • 10/17/24
Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with TevaGlobeNewsWire • 10/17/24
Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024GlobeNewsWire • 10/04/24
Kaskela Law LLC Announces Shareholder Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Investors to Contact the FirmBusiness Wire • 09/17/24
UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024GlobeNewsWire • 09/03/24
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024GlobeNewsWire • 09/03/24